Shalom ʿAlekhem : zayne ṿikhṭigsṭe ṿerḳ, zayn humor un zayn orṭ in der idisher liṭeraṭur

Sh. Niger

Ms. hebr. oct. 86 - Liḳuṭe dinim

Vorbesitzer: Eljāqīm Carmoly; Abraham Merzbacher

Liṭerarishe silueṭn

fun Ḥayim Liberman

Yudishe neshomes̀. Liṭa

A. Liṭwin [[Elektronische Ressource]] : Bd. 2

Liṭa

A. Liṭwin [[Elektronische Ressource]] : Bd. 1

Choking under Pressure und Ego Depletion: Eine Erweiterung der Attentional Control Theory und mögliche Interventionsmaßnahmen

In Leistungssituationen sind Athletinnen und Athleten nicht immer dazu in der Lage, ihr Leistungsoptimum abzurufen. Auch wenn die Befundlage zum Angst-Leistungszusammenhang äußerst heterogen ist, so geht höheres Angsterleben häufig mit Leistungsbeeinträchtigungen einher. In dem vorliegenden Manuskript wird ein Überblick über verschiedene theoretische Modelle zur Erklärung des Angst-Leistungszusammenhangs gegeben. Der Fokus wird dabei auf die Attentional Control Theory gelegt, die besagt, dass unter Druck die Aufmerksamkeitsregulation weniger effizient ausfällt und folglich erhöhte Ablenkbarkeit die Leistung negativ beeinflusst. Es wird weiterhin argumentiert, dass die Selbstkontrollkraft den Angst-Leistungszusammenhang moderiert, so dass nur bei Personen mit temporär erschöpfter Selbstkontrollkraft ein negativer Angst-Leistungszusammenhang erwartet wird, wohingegen Personen mit momentan verfügbarer Selbstkontrollkraft trotz erhöhten Angsterlebens Höchstleistung erbringen können. Abschließend werden offene Fragestellungen thematisiert, alternative Erklärungsansätze vorgestellt sowie praktische Implikationen für die Sportpsychologie abgeleitet.

The influence of ego depletion on sprint start performance in athletes without track and field experience

We tested the assumption that ego depletion would affect the sprint start in a sample of N = 38 athletes without track and field experience in an experiment by applying a mixed between- (depletion vs. non-depletion) within- (T1: before manipulation of ego depletion vs. T2: after manipulation of ego depletion) subjects design. We assumed that ego depletion would increase the possibility for a false start, as regulating the impulse to initiate the sprinting movement too soon before the starting signal requires self-control. In line with our assumption, we found a significant interaction as there was only a significant increase in the number of false starts from T1 to T2 for the depletion group while this was not the case for the non-depletion group. We conclude that ego depletion has a detrimental influence on the sprint start in athletes without track and field experience.

Sipurim mafliʾim shel ha-Dr. Ule-bule : sefer li-bene ha-neʿurim ṿe-la-ʿam

Bruno H. Birgel. Tirgem L. Ḥazan

Judenbegräbnisse und Leichenabführung in Leipzig : Historische Studie (Quelle: Leipziger Ratsarchiv, Ttl. LI; Bd. 15 und 87)

Arno Kapp

Idealen un virklikhkeyt in der rusisher liṭeraṭur : Bd. 2

In hebr. Schr., jidd.

Idealen un virklikhkeyt in der rusisher liṭeraṭur : Bd. 1

In hebr. Schr., jidd.

Śefatenu : ḳovets muḳdash li-sheʾelot harḥavatah u-teḥiyatah shel ha-lashon ha-ʿIvrit

ha-ʿorekh: Yosef Ḳlozner

Activation of RARα induces autophagy in SKBR3 breast cancer cells and depletion of key autophagy genes enhances ATRA toxicity

All-trans retinoic acid (ATRA), a pan-retinoic acid receptor (RAR) agonist, is, along with other retinoids, a promising therapeutic agent for the treatment of a variety of solid tumors. On the one hand, preclinical studies have shown promising anticancer effects of ATRA in breast cancer; on the other hand, resistances occurred. Autophagy is a cellular recycling process that allows the degradation of bulk cellular contents. Tumor cells may take advantage of autophagy to cope with stress caused by anticancer drugs. We therefore wondered if autophagy is activated by ATRA in mammary tumor cells and if modulation of autophagy might be a potential novel treatment strategy. Indeed, ATRA induces autophagic flux in ATRA-sensitive but not in ATRA-resistant human breast cancer cells. Moreover, using different RAR agonists as well as RARα-knockdown breast cancer cells, we demonstrate that autophagy is dependent on RARα activation. Interestingly, inhibition of autophagy in breast cancer cells by either genetic or pharmacological approaches resulted in significantly increased apoptosis under ATRA treatment and attenuated epithelial differentiation. In summary, our findings demonstrate that ATRA-induced autophagy is mediated by RARα in breast cancer cells. Furthermore, inhibition of autophagy results in enhanced apoptosis. This points to a potential novel treatment strategy for a selected group of breast cancer patients where ATRA and autophagy inhibitors are applied simultaneously.

CD4 T cells are required for both development and maintenance of disease in a new mouse model of reversible colitis

Current therapies to treat inflammatory bowel diseases have limited efficacy, significant side effects, and often wane over time. Little is known about the cellular and molecular mechanisms operative in the process of mucosal healing from colitis. To study such events, we developed a new model of reversible colitis in which adoptive transfer of CD4(+)CD45RB(hi) T cells into Helicobacter typhlonius-colonized lymphopenic mice resulted in a rapid onset of colonic inflammation that was reversible through depletion of colitogenic T cells. Remission was associated with an improved clinical and histopathological score, reduced immune cell infiltration to the intestinal mucosa, altered intestinal gene expression profiles, regeneration of the colonic mucus layer, and the restoration of epithelial barrier integrity. Notably, colitogenic T cells were not only critical for induction of colitis but also for maintenance of disease. Depletion of colitogenic T cells resulted in a rapid drop in tumor necrosis factor α (TNFα) levels associated with reduced infiltration of inflammatory immune cells to sites of inflammation. Although neutralization of TNFα prevented the onset of colitis, anti-TNFα treatment of mice with established disease failed to resolve colonic inflammation. Collectively, this new model of reversible colitis provides an important research tool to study the dynamics of mucosal healing in chronic intestinal remitting-relapsing disorders.Mucosal Immunology advance online publication 16 September 2015; doi:10.1038/mi.2015.93.

Eseyen un kriṭiḳ ṿegn liṭeraṭur un ḳunsṭ

Itskhoḳ Isaḳson